L. Tiffany Lyle
- Biomaterials top 10%
- Nanoparticle-Based Drug Delivery 5
- Pharmaceutical Science top 10%
-
- Cancer Diagnosis and Treatment 2
-
- Barrier Structure and Function Studies 3
-
- RNA Interference and Gene Delivery 3
-
- Cancer Research and Treatments 2
-
- Dendrimers and Hyperbranched Polymers 2
-
- Brain Metastases and Treatment 2
-
- Wound Healing and Treatments 2
- Co-authors
- Yoon YeoHyesun HyunGözde UzunallıJi Eun ParkWooin LeeJoonyoung ParkChristina M. AnnunziataAnne M. Noonan
- Journals
- Oncotarget (2 papers)Proceedings of the National Academy of Sciences (2 papers)Clinical Cancer Research (1 paper)
- Partner nations
- United StatesEgyptSouth Korea
In The Last Decade
L. Tiffany Lyle
21 papers receiving 821 citations
Peers
Comparison fields: 5 of 100
- Biomaterials 187
- Cancer Research 114
- Pharmaceutical Science 44
- Oncology 178
- Neurology 50
Countries citing papers authored by L. Tiffany Lyle
This map shows the geographic impact of L. Tiffany Lyle's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by L. Tiffany Lyle with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites L. Tiffany Lyle more than expected).
Fields of papers citing papers by L. Tiffany Lyle
This network shows the impact of papers produced by L. Tiffany Lyle. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by L. Tiffany Lyle. The network helps show where L. Tiffany Lyle may publish in the future.
Co-authorship network
The 25 scholars most cited alongside L. Tiffany Lyle, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 1 | |
| 2 | 2022 | 18 | |
| 3 | 2022 | 24 | |
| 4 | 2021 | 52 | |
| 5 | 2021 | 24 | |
| 6 | 2021 | 4 | |
| 7 | 2021 | 46 | |
| 8 | 2021 | 9 | |
| 9 | 2020 | 25 | |
| 10 | Development of Liposomal Gemcitabine with High Drug Loading Capacity | 2019 | 1 |
| 11 | 2019 | 54 | |
| 12 | 2019 | 69 | |
| 13 | 2019 | 4 | |
| 14 | 2018 | 122 | |
| 15 | 2018 | 7 | |
| 16 | 2018 | 18 | |
| 17 | 2017 | 74 | |
| 18 | 2016 | 120 | |
| 19 | 2016 | 88 | |
| 20 | 2015 | 34 |
About L. Tiffany Lyle
L. Tiffany Lyle is a scholar working on Neurology, Biomaterials and Rehabilitation, having authored 21 papers that have together received 831 indexed citations. Recurring topics across this work include Nanoparticle-Based Drug Delivery (5 papers), RNA Interference and Gene Delivery (3 papers), Barrier Structure and Function Studies (3 papers), Cancer Research and Treatments (2 papers), Dendrimers and Hyperbranched Polymers (2 papers), Brain Metastases and Treatment (2 papers), Wound Healing and Treatments (2 papers) and Cancer Diagnosis and Treatment (2 papers). The work is most often cited by research in Biomaterials (187 citations), Cancer Research (114 citations) and Pharmaceutical Science (44 citations). L. Tiffany Lyle has collaborated with scholars based in United States, Egypt and South Korea. Frequent co-authors include Yoon Yeo, Hyesun Hyun, Gözde Uzunallı, Ji Eun Park, Wooin Lee, Joonyoung Park, Christina M. Annunziata, Anne M. Noonan, Loganathan Rangasamy and Andrea L. Kasinski. Their work appears in journals such as Oncotarget, Proceedings of the National Academy of Sciences, Clinical Cancer Research, Cell Death Discovery and Frontiers in Veterinary Science.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.